# Levicept

**Canonical:** https://apis.io/providers/levicept/  
**Website:** https://levicept.com/  
**APIs profiled:** 0

Levicept Ltd is a UK-based clinical-stage biotechnology company headquartered at Innovation House, Discovery Park in Sandwich, Kent, developing LEVI-04, a fully human chimeric fusion protein combining the Fc fragment of human immunoglobulin G1 with the p75 neurotrophin receptor (p75NTR) for the treatment of chronic pain. LEVI-04 is a first-in-class neurotrophin-3 (NT-3) inhibitor designed to restore neurotrophin homeostasis and deliver analgesia without the use-limiting side effects — notably rapidly progressive osteoarthritis — seen with anti-NGF antibodies. The company completed a 510+ participant Phase II study in osteoarthritis of the knee (NCT05618782) that met all primary and secondary endpoints, published the results in The Lancet in March 2026, and had its IND accepted by the US FDA in January 2026. Levicept is backed by Medicxi, Pfizer Ventures, Gilde Healthcare, Advent Life Sciences and Innovate UK. Levicept is a therapeutics developer, not a software vendor: it operates a WordPress corporate website and publishes no API, SDK, developer portal or machine-readable contract of any kind.

## Kin Score — 7.6 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 7.6).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Levicept Domain Security** — TLSv1.3 · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Therapeutics, Clinical Trials, Chronic Pain, Osteoarthritis, United Kingdom

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/levicept/). Scores are computed from the provider's own public artifacts under a published rubric.